Monitor study Healthcare in Switzerland 2021 | gfs.bern

Monitor study "Healthcare in Switzerland 2021"

10.06.2021 | gfs.bern on behalf of Interpharma

The healthcare system has withstood the test of the current pandemic – albeit not completely. For example, there is a demand for faster access to novel medicines. The one-sided focus on cost issues – which has dominated the discussion in recent years – is neither effective nor helpful. Instead, the pandemic shows that Switzerland must align its system with the needs of patients in order to save lives. Read the findings from the monitor study “Healthcare in Switzerland 2021” here.

For about a year now, the Swiss population has been in the grip of the COVID 19 pandemic. The health crisis has not only led to elementary cuts in everyday life, but is also reshaping our view of social and political issues. What becomes visible: The COVID 19 pandemic as a health crisis did not fundamentally change attitudes and demands towards the Swiss health system. However, it has provided important impulses that have changed mindsets and sharpened demands at individual points. The detailed results are listed in the Interpharma publication in German and French.

The study results are based on a representative survey of 1,200 Swiss voters. The survey was conducted between 29 January and 5 March 2021 by means of personal interviews (face-to-face).


If you have any questions concerning this post, please contact our expert for background information, insights and the methods and models used.

Cloé Jans

Cloé Jans

Operations Manager and Media Spokeswoman